Are you a young adult who drinks alcohol? If so, you may be eligible to participate in a research study to test the effectiveness of an app to reduce alcohol use and alcohol-related harms. Compensation provided.

To evaluate the effect of a new combination of medications on body weight and body fat mass in people with type 2 diabetes and overweight/obesity.

The purpose of this study is to examine the impact of one's occupation on physical responses, specifically performance fatigability, to mental stress.

Do you live in the Appalachian region of Ohio and are you currently pregnant? Then I'd like to hear about your experience! Compensation provided.

This research study (IRB # 24-3153) involves completing an attention task on the computer with an EEG cap on your head. The attention task itself will take 50 minutes. The whole study (questionnaires, EEG setup, and study conclusion) will take two hours. This study aims to explore aspects of attention and to understand what happens in the brain when attention stays on something. Participants who have completed the study will earn $20 for their participation.

Are you a nurse in Saudi Arabia? We want to hear from you! Join our UNC study to share your thoughts on using genetics in nursing. Your feedback will help shape better nursing education and support your daily work.

Do you exercise regularly? Are you between 18-35 years old? If so, you may be eligible to participate in a research study examining how the brain, eyes, and heart work together to maintain balance. Compensation provided.

The purpose of this immunotherapy study is to compare two different chemotherapy treatments administered before breast cancer surgery to see which has the better outcome.

Do you have a blood cancer or have received a stem cell transplant and have been diagnosed with a respiratory infection? If so, you might be eligible to take part in a study to see if an experimental treatment is effective at reducing the severity of the respiratory infection.

An important goal of this study is to evaluate the length of time cancer is not growing or spreading in participants when treated with zanzalintinib compared to everolimus. In addition, this study will also evaluate if zanzalintinib can shrink tumors and help participants live longer as compared to everolimus. This information will help researchers learn if zanzalintinib can be used to treat neuroendocrine cancer.